>

MEETINGS / EVENTS

RSS

November 08 - 09 2014, 12:00 AM - 12:00 AM

ASA Quality Meeting 2014

January 23 - 25 2015, 12:00 AM - 12:00 AM

ASA PRACTICE MANAGEMENT 2015

February 07 - 08 2015, 12:00 AM - 12:00 AM

ASA Certificate in Business Administration 2015

>

FDA MEDWATCH ALERTS

October 20, 2014

Lidocaine HCI Injection, USP 10 MG Per ML, 30 ML Single-Dose, Preservative-Free, by Hospira: Recall - Particulate Matter

Summary:

FDA Medwatch Alert 10-20-14

October 16, 2014

FDA MedWatch - LifeCare Flexible Intravenous Solutions by Hospira, Inc.: Recall - Potential for Leakage

Summary:

FDA MedWatch LifeCare Flexible Intravenous Solutions by Hospira Inc

October 13, 2014

FDA MedWatch - CareFusion EnVe and ReVel Ventilators: Class 1 Recall - Power Connection Failure

Summary:

FDA MedWatch CareFusion EnVe and ReVel Ventilators

>

ASA FEATURED PRODUCT

Add this product to your shopping cart

Self-Education and Evaluation (SEE) Program

SKU: 30701-14CE

... Read more »

Single Copies, Member Price: $360

Washington Alerts

Alerts By Date

421–440 of 618 results
Show:

Friday, June 24, 2011

ASA Convenes Drug Shortage Summit Work Group

ASA Convenes Drug Shortage Summit Work Group

view details »

Monday, June 20, 2011

Host a Site Visit for Lawmakers

Host a Site Visit

view details »

Wednesday, June 15, 2011

CBO Releases Physician Payment Options

CBO Releases Physician Payment Options

view details »

Wednesday, June 08, 2011

ASA Sends Letter to FDA on Drug Shortages

ASA Send Letter to FDA on Drug Shortages

view details »

Tuesday, June 07, 2011

Participation Needed - 2011 Commercial Conversion Factor Survey

Participation Needed 2011 Commercial Conversion Factor Survey

view details »

Friday, June 03, 2011

ASA Responds to Accountable Care Organization Proposed Rule

ASA Responds to Accountable Care Organization Proposed Rule

view details »

Thursday, June 02, 2011

House Republican Health Professionals Send Letter Opposing IPAB

House Republican Health Professionals Send Letter Opposing IPAB

view details »

Tuesday, May 31, 2011

ASA Responds to Federal Trade Commission's Proposed Statement on ACO Antitrust Enforcement

ASA Responds to Federal Trade Commissions Proposed Statement on ACO Enforcement

view details »

Tuesday, May 31, 2011

Connecticut Latest State to Pass Truth in Advertising Legislation

Connecticut Latest State to Pass Truth in Advertising Legislation

view details »

Wednesday, May 25, 2011

7 Senators Request CMS Withdraw the ACO Proposed Rule

7 Senators Request CMS Withdraw the ACO Proposed Rule

view details »

Thursday, May 19, 2011

New Interpretive Guidelines Implementation Templates Released

New Interpretive Guidelines Implementation Templates Released

view details »

Tuesday, May 17, 2011

The Joint Commission Adopts ASA Recommendations on Medication Management Issues

The Joint Commission Adopts ASA Recommendations on Medication Management Issues

view details »

Tuesday, May 17, 2011

CMS Innovation Center Announces 3 New Programs Related to ACOs

CMS Innovation Center Announces 3 New Programs Related to ACOs

view details »

Monday, May 16, 2011

Poll Find Americans Want Medical Liability Reform

Poll Find Americans Want Medical Liability Reform

view details »

Tuesday, May 10, 2011

Record Attendance at 2011 Legislative Conference

Record Attendance at 2011 Legislative Conference

view details »

Monday, May 09, 2011

Senators Blumenthal, Casey and Harkin Request GAO Investigation into Drug Shortages

Senators Blumenthal Casey and Harkin Request GAO Investigation into Drug Shortages

view details »

Monday, May 09, 2011

CMS Announces National Version 5010 Testing Day

CMS Announces National Version 5010 Testing Day

view details »

Wednesday, May 04, 2011

Latest Drug Shortage - Phenylephrine

Latest Drug Shortage - Phenylephrine

view details »

Saturday, April 30, 2011

ASA Joins Obama Administration's 'Partnership for Patients' Initiative

ASA Joins Obama Administrations Partnership for Patients Initiative

view details »

Thursday, April 28, 2011

FDA Announces Opiod Strategy

FDA Announces Opiod Strategy

view details »